Dengue structure differs at the temperatures of its human and mosquito hosts

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 17, 2013, Pages 6795-6799

  Zhang, Xinzheng ^a   Sheng, Ju ^a   Plevka, Pavel ^a   Kuhn, Richard J ^a   Diamond, Michael S ^b   Rossmann, Michael G ^a  

^a PURDUE UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cryo EM; Host temperature; Irreversible and conformational change; Temperature dependence

Indexed keywords

ARTICLE; BODY TEMPERATURE; CONFORMATIONAL TRANSITION; CRYOELECTRON MICROSCOPY; CRYSTAL STRUCTURE; DENGUE; DENGUE VIRUS; HOST; HOST CELL; HUMORAL IMMUNITY; IMMATURE VIRUS; MOSQUITO; NONHUMAN; PARASITE VECTOR; PH; PRIORITY JOURNAL; PROTEIN DEGRADATION; RECEPTOR BINDING; ROOM TEMPERATURE; TEMPERATURE; TRANSITION TEMPERATURE; VIRION; WEST NILE FLAVIVIRUS;

ANIMALS; BODY TEMPERATURE; CRYOELECTRON MICROSCOPY; CULICIDAE; DENGUE VIRUS; HUMANS; MODELS, MOLECULAR; VIRAL ENVELOPE PROTEINS; VIRAL PLAQUE ASSAY; VIRION;

DENGUE VIRUS;

EID: 84876842073     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1304300110     Document Type: Article

References (41)

1. Burke DS, Monath TP (2001) Flaviviruses. Fields Virology, eds Knipe DM, Howley PM (Lippincott Williams & Wilkins, Philadelphia), 4th Ed, pp. 1043-1125.
2. Lindenbach BD, Rice CM (2001) Flaviviridae: The viruses and their replication. Fields Virology, eds Knipe DM, Howley PM (Lippincott Williams & Wilkins, Philadelphia), 4th Ed, pp. 991-1041.
3. Strauss JH (2002) Viruses and Human Disease, ed Strauss EG (Academic, San Diego).
4. Gubler DJ (2012) The economic burden of dengue. Am J Trop Med Hyg 86(5):743-744.
5. Halstead SB (2007) Dengue. Lancet 370(9599):1644-1652.
6. Halstead SB (2012) Dengue vaccine development: A 75% solution? Lancet 380(9853): 1535-1536.
7. Sabchareon A, et al. (2012) Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: A randomised, controlled phase 2b trial. Lancet 380(9853):1559-1567.
8. Kuhn RJ, et al. (2002) Structure of dengue virus: Implications for flavivirus organization, maturation, and fusion. Cell 108(5):717-725.
9. Rey FA, Heinz FX, Mandl C, Kunz C, Harrison SC (1995) The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature 375(6529):291-298.
10. Zhang Y, et al. (2004) Conformational changes of the flavivirus E glycoprotein. Structure 12(9):1607-1618.
11. Modis Y, Ogata S, Clements D, Harrison SC (2003) A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc Natl Acad Sci USA 100(12):6986-6991.
12. Crill WD, Roehrig JT (2001) Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. J Virol 75(16):7769-7773.
13. Hung JJ, et al. (2004) An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells. J Virol 78(1):378-388.
14. Bhardwaj S, Holbrook M, Shope RE, Barrett AD, Watowich SJ (2001) Biophysical characterization and vector-specific antagonist activity of domain III of the tick-borne flavivirus envelope protein. J Virol 75(8):4002-4007.
15. Zhang X, et al. (2013) Cryo-EM structure of the mature dengue virus at 3.5-Å resolution. Nat Struct Mol Biol 20(1):105-110.
16. Zhang W, et al. (2003) Visualization of membrane protein domains by cryo-electron microscopy of dengue virus. Nat Struct Biol 10(11):907-912.
17. Zhang Y, et al. (2003) Structures of immature flavivirus particles. EMBO J 22(11): 2604-2613.
18. Bressanelli S, et al. (2004) Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation. EMBO J 23(4):728-738.
19. Modis Y, Ogata S, Clements D, Harrison SC (2004) Structure of the dengue virus envelope protein after membrane fusion. Nature 427(6972):313-319.
20. van der Schaar HM, et al. (2008) Dissecting the cell entry pathway of dengue virus by single-particle tracking in living cells. PLoS Pathog 4(12):e1000244.
21. Harrison SC (2008) Viral membrane fusion. Nat Struct Mol Biol 15(7):690-698.
22. Kaufmann B, et al. (2009) Capturing a flavivirus pre-fusion intermediate. PLoS Pathog 5(11):e1000672.
23. Lok SM, et al. (2008) Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins. Nat Struct Mol Biol 15(3):312-317.
24. Austin SK, et al. (2012) Structural basis of differential neutralization of DENV-1 genotypes by an antibody that recognizes a cryptic epitope. PLoS Pathog 8(10): e1002930.
25. Dowd KA, Jost CA, Durbin AP, Whitehead SS, Pierson TC (2011) A dynamic landscape for antibody binding modulates antibody-mediated neutralization of West Nile virus. PLoS Pathog 7(6):e1002111.
26. Cherrier MV, et al. (2009) Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody. EMBO J 28(20):3269-3276.
27. Rossmann MG, Bernal R, Pletnev SV (2001) Combining electron microscopic with X-ray crystallographic structures. J Struct Biol 136(3):190-200.
28. Li L, et al. (2008) The flavivirus precursor membrane-envelope protein complex: Structure and maturation. Science 319(5871):1830-1834.
29. Yu I-M, et al. (2009) Association of the pr peptides with dengue virus at acidic pH blocks membrane fusion. J Virol 83(23):12101-12107.
30. Yu I-M, et al. (2008) Structure of the immature dengue virus at low pH primes pro-teolytic maturation. Science 319(5871):1834-1837.
31. Ferlenghi I, et al. (2001) Molecular organization of a recombinant subviral particle from tick-borne encephalitis virus. Mol Cell 7(3):593-602.
32. Caspar DLD, Klug A (1962) Physical principles in the construction of regular viruses. Cold Spring Harb Symp Quant Biol 27:1-24.
33. Kaufmann B, et al. (2006) West Nile virus in complex with the Fab fragment of a neutralizing monoclonal antibody. Proc Natl Acad Sci USA 103(33):12400-12404.
34. Stiasny K, Kössl C, Lepault J, Rey FA, Heinz FX (2007) Characterization of a structural intermediate of flavivirus membrane fusion. PLoS Pathog 3(2):e20.
35. Kaufmann B, et al. (2010) Neutralization of West Nile virus by cross-linking of its surface proteins with Fab fragments of CR4354 MAb. Proc Natl Acad Sci USA 107(44): 18950-18955.
36. Teoh EP, et al. (2012) The structural basis for serotype-specific neutralization of dengue virus by a human antibody. Sci Transl Med 4(139):139ra83.
37. Pokidysheva E, et al. (2006) Cryo-EM reconstruction of dengue virus in complex with the carbohydrate recognition domain of DC-SIGN. Cell 124(3):485-493.
38. Zhang Y, Kaufmann B, Chipman PR, Kuhn RJ, Rossmann MG (2007) Structure of immature West Nile virus. J Virol 81(11):6141-6145.
39. Tang G, et al. (2007) EMAN2: An extensible image processing suite for electron microscopy. J Struct Biol 157(1):38-46.
40. Ludtke SJ, Baldwin PR, Chiu W (1999) EMAN: Semiautomated software for high-resolution single-particle reconstructions. J Struct Biol 128(1):82-97.
41. Butrapet S, et al. (2000) Attenuation markers of a candidate dengue type 2 vaccine virus, strain 16681 (PDK-53), are defined by mutations in the 5′ noncoding region and nonstructural proteins 1 and 3. J Virol 74(7):3011-3019.